From: No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Subjects: | 13 neurosurgical patients carrying a CSF drainage |
8 M, 5 F; 26 to 82 y | |
Admitted for tumor, trauma, hemorrhage (n = 9), CSF pressure monitoring (n = 4) | |
CSF collection: | From lumbar (n = 7) or ventricular (n = 6) drainage |
Volume: 4 mL in PP Sarsted tubes, code: 62.610.201 | |
Time of day: 8.00, 12.00, 16.00, 20.00, 00.00, 8.00 | |
CSF processing: | Centrifugation within 15 min, 2000 g × 10 min at RT |
0.5 mL aliquots in PP Sarsted tubes, code: 72.730.007 | |
CSF storage: | −80 °C freezer, with controlled temperature, alarm and CO2 backup system |
Thawing: | RT with gentle shaking |
Biomarker measurement: | Immunoassay (Fujirebio): Aβ1-42, t-tau, p-tau181 |
Immunoassay (Biovendor): VILIP-1 | |
Immunoassay (R&D): YKL-40 | |
Immunoassay (Euroimmun): Aβ1-38, Aβ1-40, Aβ1-42, t-tau, ApoE | |
Immunoassay (in-house): neurogranin | |
Immunoassay (MSD): Aβx-38, Aβx-40, Aβx-42, sAPPα, sAPPβ |